目的：将慢性髓性白血病患者的白血病细胞体外诱导分化成为树突状细胞。
Objective: to induce and differentiate into dendritic cells from leukemic cells of patients with chronic myeloid leukemia.
这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。
Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.
慢性髓性白血病(CML)急变期患者WT 1基因表达水平显著高于慢性期。
The WT1 expression level of chronic myeloid leukemia (CML) in blast crisis was higher than that of CML in chronic phase.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
目的应用变性高效液相色谱(DHPLC)检测伊马替尼治疗后慢性髓性白血病(CML)患者ABL激酶区点突变。
Objective to detect the ABL point mutations in chronic myeloid leukemia (CML) patients treated with imatinib by denaturing high-performance liquid chromatography (DHPLC).
目的了解细胞程序死亡(PCD)与慢性髓细胞性白血病(CML)急变的关系。
Objective To investigate the association of the programmed cell death (PCD) regulating proteins with the acute transformation of chronic myelogenous leukemia (CML).
目的：观察典型慢性髓系白血病骨髓涂片，探讨用常规血细胞形态学方法分型的可能性。
Objective: Observation of bone marrow smears of typical chronic myeloid leukemia to investigate the Possibility of morphological classification of the disease.
目的：探讨儿童慢性髓细胞性白血病（CML）临床及实验室特征。
Objective Study on the clinical and experimental characters of the chronic myelocytic leukemia(CML)of children.
干扰素是能够产生多向性生物学效应的细胞因子家族，在毛细胞白血病、慢性髓细胞性白血病治疗中疗效显著。
Interferons, a cytokines family, a re capable of producing multiplex biological effects, and have remarkable curative effects on hair cell leukemia and chronic myelogenous leukemia.
该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。
The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.
而格列卫，来自于慢性髓细胞性白血病的药物。Vogelstein说：“我们的工作提示大多数实体肿瘤实际上不同于CML。”
While Gleevec, a pill, transformed the treatment of a blood cancer called chronic myeloid leukemia, "our work suggests that most solid tumors are really nothing like CML," Vogelstein said.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
“慢性”白血病少有或几乎没有母细胞。与急性白血病相比，“慢性淋巴细胞性白血病”和“慢性髓细胞性白血病”通常进程相对缓慢。
"Chronic" leukemias have few or no blast cells. "chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.
应用推荐